Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes
Cell · 2026-04 · 189 (9) · 2556-2572.e19
DOI: 10.1016/j.cell.2026.02.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026-04. Verfasst von Jing Xing und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA. Hauptthemen laut MEDLINE: Deep Learning, Drug Discovery, Transcriptome. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.
- Asian Liver Center, Department of Surgery, School of Medicine, Stanford University, Stanford, CA 94305, USA.
- Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA; Center for AI-Enabled Drug Discovery, College of Human Medicine, Michigan State Universi…
- Department of Computer Science and Engineering, College of Engineering, Michigan State University, East Lansing, MI 48824, USA.
- Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.
- Richard DeVos Heart and Lung Transplant Program, Corewell Health, Grand Rapids, MI 49503, USA.
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- Michigan State University
- National Institute of General Medical Sciences
- National Science Foundation
Zitieren
APA
Xing, J., Tan, M., Leshchiner, D., Sun, M., Abdelgied, M., Huang, L., Paithankar, S., Uhl, K., Shankar, R., Lisabeth, E., Aleiwi, B., Jager, T., Lawson, C., Chen, R., Giletto, M., Girgis, R., Neubig, R. R., So, S., Ellsworth, E., …, & Chen, B. (2026). Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes. Cell, 189(9), 2556-2572.e19. https://doi.org/10.1016/j.cell.2026.02.016
Vancouver
Xing J, Tan M, Leshchiner D, Sun M, Abdelgied M, Huang L, et al. Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes. Cell. 2026;189(9):2556-2572.e19. doi:10.1016/j.cell.2026.02.016
BibTeX
@article{Xing2026,
author = {Xing, Jing and Tan, Mingdian and Leshchiner, Dmitry and Sun, Mengying and Abdelgied, Mohamed and Huang, Li and Paithankar, Shreya and Uhl, Katie and Shankar, Rama and Lisabeth, Erika and Aleiwi, Bilal and Jager, Tara and Lawson, Cameron and Chen, Ruoqiao and Giletto, Matthew and Girgis, Reda and Neubig, Richard R and So, Samuel and Ellsworth, Edmund and Li, Xiaopeng and Chua, Mei-Sze and Zhou, Jiayu and Chen, Bin},
title = {Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes},
journal = {Cell},
year = {2026},
volume = {189},
number = {9},
pages = {2556--2572.e19},
doi = {10.1016/j.cell.2026.02.016}
}
EUVIMED